Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 136โ€“150 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3920
BBS1 Gene Bardet-Biedl Syndrome Type 1 Genetic Test (NGS)

This test analyzes the BBS1 gene using Next Generation Sequencing (NGS) to detect pathogenic variants associated with Bardet-Biedl Syndrome Type 1.

Whole Blood (Peripheral) or Extracted DNA / FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BBS1 gene", "Missense variants", "Nonsense variants", "Frameshift variants", "Splice-site variants", "Deep intronic variants"]
Parameters
[]
Preparation
["No special dietary or medication preparation is needed", "Continue all prescribed therapies unless advised otherwise by your physician"]
Indications
["Suspected Bardet-Biedl Syndrome Type 1", "Family history of Bardet-Biedl Syndrome Type 1", "Need for genetic counselling regarding BBS1-related risks"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94267-3 ICD-10: Q87.8
Clinical summary
This test analyzes the BBS1 gene using Next Generation Sequencing (NGS) to detect pathogenic variants associated with Bardet-Biedl Syndrome Type 1.
TEST-3958
BBS12 Gene (Bardet-Biedl Syndrome Type 12) Genetic Test

This test identifies pathogenic variants in the BBS12 gene to confirm a diagnosis of Bardet-Biedl syndrome type 12.

Whole Blood (EDTA), Extracted DNA, Dried Blood Spot (FTA Card) 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BBS12 gene"]
Parameters
[]
Preparation
["Fasting is not required", "Pre-test genetic counselling is mandatory"]
Indications
["Diagnosis of Bardet-Biedl syndrome type 12", "Carrier detection in at-risk family members", "Prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103204-9 ICD-10: Q87.89
Clinical summary
This test identifies pathogenic variants in the BBS12 gene to confirm a diagnosis of Bardet-Biedl syndrome type 12.
TEST-3898
BBS5 Gene Bardet-Biedl Syndrome Type 5 Genetic Test

This test identifies pathogenic variants in the BBS5 gene associated with Bardet-Biedl syndrome type 5.

Peripheral blood (EDTA), extracted DNA, or FTA card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BBS5 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"]
Parameters
[]
Preparation
["Pre-genetic counselling session required", "Completed clinical history form required"]
Indications
["Individuals with suggestive clinical features of Bardet-Biedl syndrome type 5", "Family history of ciliopathies", "Pre-test genetic counseling recommended"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: Q87.89
Clinical summary
This test identifies pathogenic variants in the BBS5 gene associated with Bardet-Biedl syndrome type 5.
TEST-6093
BCKDHA Gene Maple Syrup Urine Disease Type 1a Genetic Test

This test identifies pathogenic variants in the BCKDHA gene associated with Maple Syrup Urine Disease Type 1a.

Peripheral Whole Blood or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BCKDHA gene pathogenic variants", "Single nucleotide variants", "Small insertions and deletions", "Copy-number changes"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session", "Do not discontinue prescribed medication or initiate a leucine-restricted diet without physician supervision"]
Indications
["Suspected Maple Syrup Urine Disease Type 1a", "Carrier screening", "Family cascade screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21629-5 ICD-10: E71.0
Clinical summary
This test identifies pathogenic variants in the BCKDHA gene associated with Maple Syrup Urine Disease Type 1a.
TEST-6040
BCKDHB Gene Maple Syrup Urine Disease Type 1b Genetic Test

This test identifies pathogenic variants in the BCKDHB gene to confirm a diagnosis of Maple Syrup Urine Disease (MSUD) type 1b.

Whole Blood, Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the BCKDHB gene", "Presence of point mutations, small indels, and CNVs"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed branched-chain amino acid formula or dietary management without consulting a metabolic specialist"]
Indications
["Suspected diagnosis of Maple Syrup Urine Disease (MSUD) type 1b", "Differential diagnosis in patients with metabolic acidosis", "Cascade screening for at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21638-3 ICD-10: E71.0
Clinical summary
This test identifies pathogenic variants in the BCKDHB gene to confirm a diagnosis of Maple Syrup Urine Disease (MSUD) type 1b.
TEST-6047
BCKDK Gene Genetic Test for Branched-Chain Ketoacid Dehydrogenase Kinase Deficiency

This test identifies genetic mutations in the BCKDK gene associated with branched-chain ketoacid dehydrogenase kinase deficiency.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BCKDK gene sequence", "Pathogenic variants in BCKDK gene"]
Parameters
[]
Preparation
["Inform laboratory of recent blood transfusion (within 4 weeks)", "Notify phlebotomist if on anticoagulant therapy"]
Indications
["Diagnosis of BCKDK deficiency", "Carrier screening", "Prenatal testing", "Family risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92737-7 ICD-10: E71.1
Clinical summary
This test identifies genetic mutations in the BCKDK gene associated with branched-chain ketoacid dehydrogenase kinase deficiency.
TEST-1836
BCL6 Gene Rearrangement (FISH) Test

This test detects chromosomal rearrangements of the BCL6 gene using Fluorescence In-Situ Hybridization (FISH). It is a key molecular marker for classifying and understanding B-cell...

Bone marrow aspirate or peripheral whole blood 5โ€“6 working days 900.00 AED
View
View test specifications and preparation
What it measures
["BCL6 gene rearrangements", "Chromosomal translocations at 3q27"]
Parameters
[]
Preparation
["No special fasting required"]
Indications
["Classification of B-cell lymphomas", "Prognostic assessment in lymphoma", "Guiding targeted therapy decisions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 49583-7 ICD-10: C83.9
Clinical summary
This test detects chromosomal rearrangements of the BCL6 gene using Fluorescence In-Situ Hybridization (FISH). It is a key molecular marker for classifying and understanding B-cell lymphomas.
TEST-5157
BCS1L Gene Mitochondrial Complex III Deficiency Genetic Test

This genetic test evaluates the BCS1L gene for pathogenic variants associated with mitochondrial complex III deficiency.

Peripheral whole blood (EDTA) or buccal swab 12โ€“18 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["BCS1L gene coding sequence", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Exon-level copy number variants (CNVs)"]
Parameters
[]
Preparation
["A detailed clinical history is required.", "A formal genetic counselling session to draw a pedigree chart is mandatory."]
Indications
["Suspected mitochondrial complex III deficiency", "Neonatal-onset encephalopathy", "Hepatopathy", "Renal tubulopathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93336-6 ICD-10: E88.49, G31.81
Clinical summary
This genetic test evaluates the BCS1L gene for pathogenic variants associated with mitochondrial complex III deficiency.
TEST-398
Beta-2 Transferrin (CSF) Test

This diagnostic test specifically identifies the presence of Beta-2 Transferrin, a protein unique to cerebrospinal fluid, in samples other than CSF.

Cerebrospinal Fluid (CSF) 2โ€“3 weeks 7,500.00 AED
View
View test specifications and preparation
What it measures
["Beta-2 Transferrin (desialylated transferrin isoform)", "Presence of CSF in non-CSF samples"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis of CSF leak", "Differentiation of CSF from other fluids"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 4811-3 ICD-10: G96.0
Clinical summary
This diagnostic test specifically identifies the presence of Beta-2 Transferrin, a protein unique to cerebrospinal fluid, in samples other than CSF.
TEST-5733
BICD2 Gene Sequencing for Spinal Muscular Atrophy, Lower Extremity, Autosomal Dominant Type 2 (NGS) Test

This diagnostic test evaluates the BICD2 gene for pathogenic variants associated with autosomal dominant lower extremity spinal muscular atrophy type 2.

Blood, Extracted DNA, or Dried Blood Spot (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BICD2 gene sequence", "Pathogenic variants in BICD2"]
Parameters
[]
Preparation
["No special preparation needed"]
Indications
["Suspected lower extremity-predominant spinal muscular atrophy type 2", "Family history of autosomal dominant spinal muscular atrophy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95277-6 ICD-10: G12.1
Clinical summary
This diagnostic test evaluates the BICD2 gene for pathogenic variants associated with autosomal dominant lower extremity spinal muscular atrophy type 2.
TEST-412
Biotinidase Activity Quantitative Blood Test

This test measures the functional activity of the biotinidase enzyme in serum or plasma to diagnose biotinidase deficiency.

Serum or plasma (peripheral venous blood) Same day (sample received by 4 pm) 650.00 AED
View
View test specifications and preparation
What it measures
["Biotinidase enzyme activity", "Biotin recycling pathway function"]
Parameters
[{"name": "Biotinidase Activity", "reference_range": "8 - 19 nmol/min/mL"}]
Preparation
["No fasting required", "Continue prescribed biotin or multivitamins unless advised otherwise by the physician", "Ensure child is well-hydrated"]
Indications
["Newborn screening follow-up", "Suspected biotinidase deficiency based on clinical presentation", "Family history of biotinidase deficiency"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 22658-2 ICD-10: E53.8
Clinical summary
This test measures the functional activity of the biotinidase enzyme in serum or plasma to diagnose biotinidase deficiency.
TEST-418
Bismuth 24-Hour Urine Test

This diagnostic test evaluates the total amount of bismuth excreted in the urine over a 24-hour period.

24-Hour Urine 10โ€“14 Business Days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Total bismuth excretion", "Cumulative exposure to bismuth"]
Parameters
[{"name": "Bismuth", "reference_range": null}]
Preparation
["Avoid all mineral supplements and bismuth-containing products (e.g., Pepto-Bismol) for at least 1 week prior to collection.", "Use only the acid-washed metal-free container provided.", "Do not measure the 24-hour total volume.", "Ship the sample refrigerated or frozen immediately after collection.", "Duly filled Test Send Out Consent Form (Form 35) is mandatory."]
Indications
["Occupational health monitoring", "Gastroenterology applications", "Nephrology applications", "Monitoring chelation therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 14671-7 ICD-10: T56.891
Clinical summary
This diagnostic test evaluates the total amount of bismuth excreted in the urine over a 24-hour period.
TEST-415
Bismuth Random Urine Test

This test measures the concentration of bismuth in a random urine sample to assess for potential toxicity.

Random Urine 14โ€“21 calendar days 1,500.00 AED
View
View test specifications and preparation
What it measures
["Bismuth concentration in urine"]
Parameters
[{"name": "Bismuth", "reference_range": "โ‰ค0.1 ยตg/L"}]
Preparation
["Discontinue all bismuth-containing medications (e.g., bismuth subsalicylate) and mineral supplements at least seven days prior to collection.", "Use only the laboratory-supplied acid-washed, metal-free urine container.", "Complete the Test Send Out Consent Form (Form 35) in full before sample pickup."]
Indications
["Suspected occupational exposure to bismuth", "Chronic use of bismuth-containing medications", "Assessment of unexplained neurocognitive or renal dysfunction"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 5687-2 ICD-10: T56.891
Clinical summary
This test measures the concentration of bismuth in a random urine sample to assess for potential toxicity.
TEST-3343
BLNK Gene Agammaglobulinemia Type 4 (Autosomal Recessive) Genetic Test

This genetic test identifies pathogenic mutations in the BLNK gene associated with autosomal recessive agammaglobulinemia.

Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BLNK gene sequence", "Pathogenic mutations in BLNK gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected autosomal recessive agammaglobulinemia", "Recurrent sinopulmonary infections", "Pan-hypogammaglobulinemia with absent B cells", "Carrier screening in affected families", "Preimplantation genetic testing guidance"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94853-7 ICD-10: D80.0
Clinical summary
This genetic test identifies pathogenic mutations in the BLNK gene associated with autosomal recessive agammaglobulinemia.
TEST-4724
BMP1 Gene Osteogenesis Imperfecta Type 13 Genetic Test

This test evaluates the BMP1 gene for pathogenic variants associated with Osteogenesis Imperfecta Type 13.

Peripheral Whole Blood or Sterile DNA FTA Card 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["BMP1 gene pathogenic variants", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"]
Parameters
[]
Preparation
[]
Indications
["Suspected Osteogenesis Imperfecta Type 13", "Differentiation from other collagenopathies", "Genetic skeletal disorder diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93025-1 ICD-10: Q78.0
Clinical summary
This test evaluates the BMP1 gene for pathogenic variants associated with Osteogenesis Imperfecta Type 13.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area